A. Krystosek

发表

Normal and malignant cells, including neurons, deposit plasminogen activator on the growth substrata.

N. Seeds, A. Krystosek, 1986, Experimental cell research.

The farnesyl protein transferase inhibitor BZA-5B blocks farnesylation of nuclear lamins and p21ras but does not affect their function or localization.

R. Evans, M. Sinensky, L. Demaio, 1995, Cancer research.

Plasminogen Activators and Plasminogen Activator Inhibitors in Neural Development a

N. Seeds, P. McGuire, S. Hayden, 1992, Annals of the New York Academy of Sciences.

Reverse transformation and genome exposure in the C6 glial tumor cell line.

T. Puck, E. Arenson, A. Krystosek, 1994, Cancer investigation.

Reverse transformation, genome exposure, and cancer.

T. Puck, A. Krystosek, Theodore T. Puck, 1993, Advances in cancer research.

Genome regulation in mammalian cells

T. Puck, A. Krystosek, D. Chan, 1990, Somatic cell and molecular genetics.

Peripheral neurons and Schwann cells secrete plasminogen activator

N. Seeds, A. Krystosek, 1984, The Journal of cell biology.

The spatial distribution of exposed nuclear DNA in normal, cancer, and reverse-transformed cells.

T. Puck, A. Krystosek, 1990, Proceedings of the National Academy of Sciences of the United States of America.

Plasminogen activator secretion by granule neurons in cultures of developing cerebellum.

N. Seeds, A. Krystosek, 1981, Proceedings of the National Academy of Sciences of the United States of America.

Conversion to the terminally differentiated state during treatment of NG108-15 neural tumor cells with 1-beta-D-arabinofuranosylcytosine in defined medium.

A. Krystosek, Alphonse Krystosek, 1989, Cancer research.

Steroid hormone receptors and the differentiation of myeloid leukemic cells

L. Sachs, A. Krystosek, 1977, Journal of cellular physiology.

Plasminogen activators and their interaction with the extracellular matrix in neural development, plasticity and regeneration

D. Thewke, N. Seeds, P. McGuire, 1996 .

Improved methods for purification and assay of eukaryotic messenger ribonucleic acids and ribosomes. Quantitative analysis of their interaction in a fractionated reticulocyte cell-free system.

D. Kabat, M. Cawthon, A. Krystosek, 1975, The Journal of biological chemistry.

Control of lysozyme induction in the differentiation of myeloid leukemic cells

L. Sachs, A. Krystosek, 1976, Cell.

Role of the cytoskeleton in genome regulation and cancer.

T. Puck, T T Puck, A Krystosek, 1992, International review of cytology.

Confocal microscopy of genome exposure in normal, cancer, and reverse-transformed cells

T. Puck, A. Krystosek, M. Bartholdi, 1991, Somatic cell and molecular genetics.

Effect of cyclic adenosine 3':5'-monophosphate on ribosomal protein phosphorylation in reticulocytes.

D. Kabat, M. Cawthon, A. Krystosek, 1974, The Journal of biological chemistry.

Plasminogen activator release at the neuronal growth cone.

N. Seeds, A. Krystosek, 1981, Science.

Repositioning of human interphase chromosomes by nucleolar dynamics in the reverse transformation of HT1080 fibrosarcoma cells.

A. Krystosek, 1998, Experimental cell research.

Neurite formation by neuroblastoma‐glioma hybrid cells (NG108–15) in defined medium: Stochastic initiation with persistence of differentiated functions

A. Krystosek, 1985, Journal of cellular physiology.

Preferential sites of early DNA cleavage in apoptosis and the pathway of nuclear damage

A. Krystosek, 1999, Histochemistry and Cell Biology.

Phosphorylation of Ribosomal Proteins in Eukaryotes

D. Kabat, M. Cawthon, A. Krystosek, 1974 .

Plasminogen activator secretion in relation to Schwann cell activities

N. Seeds, A. Krystosek, S. Verrall, 1988, International Journal of Developmental Neuroscience.